Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity (original) (raw)

Nature Medicine volume 8, pages 179–183 (2002)Cite this article

An Erratum to this article was published on 01 March 2002

Abstract

Obesity and insulin resistance are major risk factors for a number of metabolic disorders, such as type 2 diabetes mellitus1,2. Insulin has been suggested to function as one of the adiposity signals to the brain for modulation of energy balance. Administration of insulin into the brain reduces food intake and body weight3,4,5, and mice with a genetic deletion of neuronal insulin receptors are hyperphagic and obese6. However, insulin is also an anabolic factor; when administered systemically, pharmacological levels of insulin are associated with body weight gain in patients7. In this study, we investigated the efficacy and feasibility of small molecule insulin mimetic compounds8,9 to regulate key parameters of energy homeostasis. Central intracerebroventricular (i.c.v.) administration of an insulin mimetic resulted in a dose-dependent reduction of food intake and body weight in rats, and altered the expression of hypothalamic genes known to regulate food intake and body weight. Oral administration of a mimetic in a mouse model of high-fat diet-induced obesity reduced body weight gain, adiposity and insulin resistance. Thus, insulin mimetics have a unique advantage over insulin in the control of body weight and hold potential as a novel anti-obesity treatment.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Taylor, S.I. Deconstructing type 2 diabetes. Cell 97, 9–12 (1999).
    Article CAS PubMed Google Scholar
  2. Kopelman, P.G. Obesity as a medical problem. Nature 404, 635–643 (2000).
    Article CAS PubMed Google Scholar
  3. Woods, S.C., Lotter, E.C., McKay, L.D. & Porte, D. Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503–505 (1979).
    Article CAS PubMed Google Scholar
  4. Schwartz, M.W., Figlewicz, D.P., Baskin, D.G., Woods, S.C. & Porte, D. Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13, 387–414 (1992).
    CAS PubMed Google Scholar
  5. Woods, S.C., Schwartz, M.W., Baskin, D.G. & Seeley, R.J. Food intake and the regulation of body weight. Ann. Rev. Psychol. 51, 255–277 (2000).
    Article CAS Google Scholar
  6. Bruning, J.C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–2125 (2000).
    Article CAS PubMed Google Scholar
  7. DeFronzo, R. Pharmacological therapy for type 2 diabetes. Ann. Intern. Med .17, 281–303 (1999).
    Article Google Scholar
  8. Zhang, B. et al. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284, 974–977 (1999).
    Article CAS PubMed Google Scholar
  9. Qureshi, S.A. et al. Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators. J. Biol. Chem. 275, 36590–36595 (2000).
    Article CAS PubMed Google Scholar
  10. Sipols, A.J., Baskin, D.G. & Schwartz, M.W. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44, 147–151 (1995).
    Article CAS PubMed Google Scholar
  11. Bernstein, I.L., Goehler, L.E. & Bouton, M.E. Relative potency of foods and drinks as targets in aversion conditioning. Behav. Neural. Biol. 37, 134–148 (1983).
    Article CAS PubMed Google Scholar
  12. Mitchell, D. et al. Poison induced pica in rats. Physiol. Behav. 17, 691–697 (1976).
    Article CAS PubMed Google Scholar
  13. Madden, L.J., Seeley, R.J. & Woods, S.C. Intraventricular neuropeptide Y decreases need-induced sodium appetite and increases pica in rats. Behav. Neurosci. 113, 826–832 (1999).
    Article CAS PubMed Google Scholar
  14. Stricker, E.M. & Verbalis, J.G. Central inhibitory control of sodium appetite in rats: correlation with pituitary oxytocin secretion. Behav. Neurosci. 101, 560–567 (1987).
    Article CAS PubMed Google Scholar
  15. Liu, K. et al. Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor. J. Med. Chem. 43, 3487–3494 (2000).
    Article CAS PubMed Google Scholar
  16. Lowell, B.B. et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366, 740–742 (1993).
    Article CAS PubMed Google Scholar
  17. Spiegelman, B.M. & Flier, J.S. Adipogenesis and obesity: rounding out the big picture. Cell 87, 377–389 (1996).
    Article CAS PubMed Google Scholar
  18. Kahn, B.B. & Flier, J.S. Obesity and insulin resistance. J. Clin. Invest. 106, 473–481 (2000).
    Article CAS PubMed PubMed Central Google Scholar
  19. Considine, R.V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292–295 (1996).
    Article CAS PubMed Google Scholar
  20. Elchebly, M. et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544–1548 (1999).
    Article CAS PubMed Google Scholar
  21. Klaman, L.D. et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20, 5479–5489 (2000).
    Article CAS PubMed PubMed Central Google Scholar
  22. Baura, G.D. et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92, 1824–1830 (1991).
    Article Google Scholar

Download references

Acknowledgements

We thank D. Szalkowski and Z. Li for help with necropsy and J. Ronan for help with preparation of histology slides. This work was supported in part by grants from the DFG (M.Z.S.), the American Diabetes Association (Physician Scientist Training Award to E.L.A.) and NIH (S.C.W.).

Author information

Author notes

  1. Ellen L. Air and Mathias Z. Strowski: E.L.A. and M.Z.S. contributed equally to this paper.

Authors and Affiliations

  1. Departments of Biomedical Sciences and Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
    Ellen L. Air
  2. Department of Molecular Endocrinology and Metabolic Disorders, Merck Research Laboratories, Rahway, New Jersey, USA
    Mathias Z. Strowski, Stacey L. Conarello, Xiao-Ming Guan & Bei B. Zhang
  3. Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
    Stephen C. Benoit, Kun Liu & Stephen C. Woods
  4. Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, New Jersey, USA
    Gino M. Salituro

Authors

  1. Ellen L. Air
  2. Mathias Z. Strowski
  3. Stephen C. Benoit
  4. Stacey L. Conarello
  5. Gino M. Salituro
  6. Xiao-Ming Guan
  7. Kun Liu
  8. Stephen C. Woods
  9. Bei B. Zhang

Corresponding author

Correspondence toBei B. Zhang.

Ethics declarations

Competing interests

G.M. Salituro, X.-M. Guan, K. Liu & B.B. Zhang are employees and shareholders of Merck and Co.

Rights and permissions

About this article

Cite this article

Air, E., Strowski, M., Benoit, S. et al. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity.Nat Med 8, 179–183 (2002). https://doi.org/10.1038/nm0202-179

Download citation

This article is cited by